Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

OMCL stock hub

Omnicell, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OMCLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

OMCL

In the news

Latest news · OMCL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.5

P25 12.3P50 18.4P75 33.1

Trailing P/E99.6

P25 14.9P50 23.2P75 38.5

ROE1.6

P25 -105.6P50 -46.5P75 -3.1

ROIC1.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OMCL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

262

Groups with data

Currency

USD

Showing 262 of 262 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000926326
Company name	Omnicell, Inc.
Country	United States
Country code	US
Cusip	68213N109
Employees	3,525
Employees Change	-55%
Employees Change Percent	-1.54
Enterprise value	$2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Health Information Services
IPO Date	2001-08-07
Isin	US68213N1090
Last refreshed	2026-05-10
Market cap	$2B
Market cap category	Small-Cap
Price	$43.82
Price currency	USD
Rev Per Employee	347,533.9x
Sector	Healthcare
Sic	3571
Symbol	OMCL
Website	https://www.omnicell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.03%
EV Earnings	95.72x
EV Sales Forward	1.52x
EV/EBIT	48.73x
EV/EBITDA	26.57x
EV/FCF	17.5x
EV/Sales	1.6x
FCF yield	5.61%
Forward P/E	23.51x
P/B ratio	1.59x
P/E ratio	99.58x
P/S ratio	1.63x
PE Ratio10 Y	126.25x
PE Ratio5 Y	182.31x
PEG ratio	0.79x
PS Forward	1.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.28%
EBITDA Margin	6.01%
FCF margin	9.12%
Gross margin	43.87%
Gross Profit	$537.5M
Gross Profit Growth	9.44%
Gross Profit Growth Q	26.53%
Gross Profit Growth3 Y	-2.04%
Gross Profit Growth5 Y	4.62%
Net Income	$20.4M
Net Income Growth	-3.55%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth5 Y	-10.21%
Pretax Margin	3.08%
Profit Margin	1.67%
Profit Per Employee	$5,797
Profitable Years	2
ROA	1.21
Roa5y	0.79
ROCE	2.64
ROE	1.63
Roe5y	1.46
ROIC	1.77
Roic5y	1.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.36%
Cagr15y	7.51%
Cagr1y	77.98%
Cagr20y	5.86%
Cagr3y	-12.68%
Cagr5y	-20.9%
EPS Growth	-2.85
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth5 Y	-10.96
FCF Growth	-10.6%
FCF Growth Q	185.15%
FCF Growth3 Y	22.8%
FCF Growth5 Y	-10.38%
OCF Growth	-4.78%
OCF Growth Q	110.23%
OCF Growth10 Y	13.37%
OCF Growth3 Y	13.52%
OCF Growth5 Y	-6.49%
Revenue Growth	7.86x
Revenue Growth Q	14.91x
Revenue Growth Quarters	6x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.14x
Revenue Growth5 Y	6.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.59
Assets	$2B
Cash	$239.2M
Current Assets	$722.3M
Current Liabilities	$483M
Debt	$202.2M
Debt EBITDA	$2.42
Debt Equity	$0.16
Debt FCF	$1.81
Equity	$1.3B
Interest Coverage	9.25
Liabilities	$747.5M
Long Term Assets	$1.3B
Long Term Liabilities	$264.4M
Net Cash	$37M
Net Cash By Market Cap	$1.86
Net Cash Growth	3,607.81%
Net Debt EBITDA	$-0.5
Net Debt Equity	$-0.03
Net Debt FCF	$-0.33
Tangible Book Value	$300.9M
Tangible Book Value Per Share	$6.62
WACC	8.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.5
Inventory Turnover	7.22
Net Working Capital	$11.7M
Quick ratio	1.04
Working Capital	$239.3M
Working Capital Turnover	$5.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.59%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	39.16%
1Y total return	77.91%
200-day SMA	37.22
3Y total return	-33.42%
50-day SMA	37.63
50-day SMA vs 200-day SMA	50over200
5Y total return	-69.03%
All Time High	187.3
All Time High Change	-76.6%
All Time High Date	2021-11-22
All Time Low	1.29
All Time Low Change	3,296.9%
All Time Low Date	2002-10-17
ATR	2.1
Beta	0.96
Beta1y	1.4
Beta2y	0.49
Ch YTD	-3.27
High	44.13
High52	55
High52 Date	2026-01-13
High52ch	-20.33%
Low	42.86
Low52	24.85
Low52 Date	2025-05-08
Low52ch	76.34%
Ma50ch	16.45%
Price vs 200-day SMA	17.74%
RSI	64.94
RSI Monthly	51.47
RSI Weekly	58.29
Sharpe ratio	1.35x
Sortino ratio	2.34
Total Return	0.59%
Tr YTD	-3.27
Tr15y	196.48%
Tr1m	27.01%
Tr1w	2.38%
Tr3m	18.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	1
Analyst Price Target Top	$60
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.29
Earnings EPS Estimate Growth	11.54
Earnings Revenue Estimate	303,892,664x
Earnings Revenue Estimate Growth	12.69x
Operating Income	$40.1M
Operating Income Growth	219.7
Operating Income Growth5 Y	-7.05
Operating margin	3.28
Price target	$55.83
Price Target Change	$27.41
Price Target Change Top	$36.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	41,953,915%
Float Percent	92.25%
Net Borrowing	-175,000,000
Shares Insiders	2.66%
Shares Institutions	99.88%
Shares Out	45,478,909
Shares Qo Q	2.19%
Shares Yo Y	-0.59%
Short Float	6.01%
Short Ratio	5.4
Short Shares	5.54

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$68.6M
Average Volume	639,266.75x
Bv Per Share	27.63
CAPEX	$-44.1M
Ch10y	39.16
Ch15y	196.5
Ch1m	27.01
Ch1w	2.38
Ch1y	77.91
Ch20y	212.3
Ch3m	18.21
Ch3y	-33.42
Ch5y	-69.03
Ch6m	22.81
Change	1.13%
Change From Open	1.22
Close	43.33
Days Gap	-0.09
Depreciation Amortization	33,472,000
Dollar Volume	14,070,207.6
Earnings Date	2026-04-28
Earnings Time	bmo
EBIT	$40.1M
EBITDA	$73.6M
EPS	$0.44
F Score	7
FCF	$111.8M
FCF EV Yield	5.71x
FCF Per Share	$2.46
Financing CF	-219,964,000
Fiscal Year End	December
Founded	1,992
Goodwill	737,287,000
Graham Number	16.54051
Graham Upside	-62.25
Income Tax	$17.3M
Investing CF	-60,491,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Lynch Fair Value	$2.2
Lynch Upside	-94.98
Ma150	39.17
Ma150ch	11.88%
Ma20	39.9
Ma20ch	9.82%
Net CF	-123,437,000
Next Earnings Date	2026-07-30
Open	43.29
Optionable	Yes
P FCF Ratio	17.83
P OCF Ratio	12.79
Position In Range	75.59
Post Close	43.82
Postmarket Change Percent	-0.14
Postmarket Price	$43.76
Ppne	144,454,000
Price Date	2026-05-08
Price EBITDA	$27.07
Ptbv Ratio	6.62
Relative Volume	0.5x
Revenue	1,225,057,000x
SBC By Revenue	3.53x
Share Based Comp	43,214,000
Tax By Revenue	1.41x
Tax Rate	45.89%
Tr20y	212.33%
Tr6m	22.81%
Us State	Texas
Volume	321,091
Z Score	2.37

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OMCL pay a dividend?

Capital-return profile for this ticker.

Performance

OMCL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OMCL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+99.9%

Float: +92.2% of shares outstanding

Insider ownership

+2.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

OMCL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.9

Neutral momentum band

Price vs 200-day MA

+17.7%

50/200-day relationship not available

Beta (5Y)

0.96

Moves roughly with the market

Sharpe ratio

1.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OMCL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current OMCL stock rating?

Omnicell, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full OMCL analysis?

The full report lives at /stocks/OMCL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for OMCL?

The latest report frames OMCL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the OMCL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.